Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Longitudinal outcomes following international multicentre experience with robotic aortic valve replacement†

LM. Wei, D. Pereda, D. Ramzy, FH. Khaliel, G. Murtaza, JH. Mehaffey, NH. Chi, R. Poffo, Š. Černý, J. Vojáček, TD. Yan, S. Melnitchouk, AC. Weber, RL. Smith, GV. Raikar, A. Darehzereshki, A. Geirsson, A. Arghami, JL. Navia, J. Bonatti, V. Badhwar

. 2025 ; 67 (4) : . [pub] 20250328

Language English

Document type Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc25016336

Grant support
# 2UM1 HL088925 12 National Insitute of Health National Heart Lung Blood Institute

OBJECTIVES: In an effort to maintain the technical aspects of traditional prosthetic surgical aortic valve replacement (AVR) while reducing invasiveness and facilitate options for concomitant operations, transaxillary lateral mini-thoracotomy endoscopic robotic-assisted aortic valve replacement (RAVR) has been introduced. The present data highlight the contemporary international collaborative experience. METHODS: All consecutive patients undergoing standardized RAVR across 10 international sites (1/2020-7/2024) were evaluated using a central database with 1 year follow-up. RESULTS: A total of 300 patients were analysed with a median predicted risk of 1.6% with aortic stenosis in 85.7%, nearly half with bicuspid valves. Biological prostheses were implanted in 220 (73.3%) with a median valve size 23 mm, 10% receiving aortic root enlargement, with 17% of all patients undergoing concomitant procedures. Median cross-clamp 120 min with no conversions to sternotomy. Median length of stay was 5 days, 4.3% with prolonged ventilation, 1.7% renal failure, 1.0% stroke and 8.3% required re-thoracotomy for evacuation of haemothorax. There were two 30-day operative mortalities (0.7%). The new permanent pacemaker rate for the full cohort was 2.6%. Of 163 patients with complete 1-year clinical and echocardiographic follow-up, mean aortic valve gradient was 10 mmHg and all but 2 patients (1.2%) had trace to no prosthetic or paravalvular insufficiency. CONCLUSIONS: RAVR is safe and effective, providing the reproducible benefits of surgical AVR while affording a less invasive approach that permits the opportunity for concomitant procedures. For low and intermediate risk patients with aortic valve disease, RAVR is a potential reproducible alternative for patients and heart teams.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016336
003      
CZ-PrNML
005      
20250731092837.0
007      
ta
008      
250708s2025 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ejcts/ezaf103 $2 doi
035    __
$a (PubMed)40131409
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Wei, Lawrence M $u Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA
245    10
$a Longitudinal outcomes following international multicentre experience with robotic aortic valve replacement† / $c LM. Wei, D. Pereda, D. Ramzy, FH. Khaliel, G. Murtaza, JH. Mehaffey, NH. Chi, R. Poffo, Š. Černý, J. Vojáček, TD. Yan, S. Melnitchouk, AC. Weber, RL. Smith, GV. Raikar, A. Darehzereshki, A. Geirsson, A. Arghami, JL. Navia, J. Bonatti, V. Badhwar
520    9_
$a OBJECTIVES: In an effort to maintain the technical aspects of traditional prosthetic surgical aortic valve replacement (AVR) while reducing invasiveness and facilitate options for concomitant operations, transaxillary lateral mini-thoracotomy endoscopic robotic-assisted aortic valve replacement (RAVR) has been introduced. The present data highlight the contemporary international collaborative experience. METHODS: All consecutive patients undergoing standardized RAVR across 10 international sites (1/2020-7/2024) were evaluated using a central database with 1 year follow-up. RESULTS: A total of 300 patients were analysed with a median predicted risk of 1.6% with aortic stenosis in 85.7%, nearly half with bicuspid valves. Biological prostheses were implanted in 220 (73.3%) with a median valve size 23 mm, 10% receiving aortic root enlargement, with 17% of all patients undergoing concomitant procedures. Median cross-clamp 120 min with no conversions to sternotomy. Median length of stay was 5 days, 4.3% with prolonged ventilation, 1.7% renal failure, 1.0% stroke and 8.3% required re-thoracotomy for evacuation of haemothorax. There were two 30-day operative mortalities (0.7%). The new permanent pacemaker rate for the full cohort was 2.6%. Of 163 patients with complete 1-year clinical and echocardiographic follow-up, mean aortic valve gradient was 10 mmHg and all but 2 patients (1.2%) had trace to no prosthetic or paravalvular insufficiency. CONCLUSIONS: RAVR is safe and effective, providing the reproducible benefits of surgical AVR while affording a less invasive approach that permits the opportunity for concomitant procedures. For low and intermediate risk patients with aortic valve disease, RAVR is a potential reproducible alternative for patients and heart teams.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a aortální chlopeň $x chirurgie $7 D001021
650    12
$a roboticky asistované výkony $x metody $x škodlivé účinky $x mortalita $x statistika a číselné údaje $7 D065287
650    12
$a chirurgická náhrada chlopně $x metody $x škodlivé účinky $x mortalita $7 D019918
650    _2
$a výsledek terapie $7 D016896
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a aortální stenóza $x chirurgie $7 D001024
650    _2
$a srdeční chlopně umělé $7 D006350
650    _2
$a následné studie $7 D005500
650    _2
$a torakotomie $x metody $7 D013908
650    _2
$a longitudinální studie $7 D008137
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Pereda, Daniel $u Department of Cardiovascular Surgery, University of Barcelona, Barcelona, Spain $1 https://orcid.org/0000000205268722
700    1_
$a Ramzy, Danny $u Division of Cardiac Surgery, McGovern Medical School, UTHealth, Houston, TX, USA
700    1_
$a Khaliel, Feras H $u Division of Cardiac Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
700    1_
$a Murtaza, Ghulam $u Division of Cardiothoracic Surgery, SSM Health St Mary's Hospital, Madison, WI, USA
700    1_
$a Mehaffey, James Hunter $u Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA
700    1_
$a Chi, Nai-Hsin $u Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
700    1_
$a Poffo, Robinson $u Department of Cardiovascular Surgery, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
700    1_
$a Černý, Štěpán $u Department of Cardiac Surgery, University Hospital Motol, Prague, Czech Republic
700    1_
$a Vojáček, Jan $u Department of Cardiac Surgery, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Yan, Tristan D $u Department of Cardiothoracic Surgery, The Royal Prince Alfred Hospital, Sydney, Australia
700    1_
$a Melnitchouk, Serguei $u Division of Cardiac Surgery, Massachusetts General Hospital, Boston, MA, USA
700    1_
$a Weber, Alberto C $u Department of Cardiovascular Surgery, Herzzentrum Hirslanden, Zurich, Switzerland
700    1_
$a Smith, Robert L $u Division of Cardiac Surgery, Baylor Scott & White Health, Plano, TX, USA
700    1_
$a Raikar, Goya V $u Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA
700    1_
$a Darehzereshki, Ali $u Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA
700    1_
$a Geirsson, Arnar $u Division of Adult Cardiac Surgery, Presbyterian Hospital, Columbia University, New York, NY, USA
700    1_
$a Arghami, Arman $u Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/0000000273980738
700    1_
$a Navia, Jose L $u Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Florida, Weston, FL, USA
700    1_
$a Bonatti, Johannes $u Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA
700    1_
$a Badhwar, Vinay $u Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA $1 https://orcid.org/0000000279163544
773    0_
$w MED00001607 $t European journal of cardio-thoracic surgery $x 1873-734X $g Roč. 67, č. 4 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40131409 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092831 $b ABA008
999    __
$a ok $b bmc $g 2366892 $s 1253461
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 67 $c 4 $e 20250328 $i 1873-734X $m European journal of cardio-thoracic surgery $n Eur J Cardiothorac Surg $x MED00001607
GRA    __
$a # 2UM1 HL088925 12 $p National Insitute of Health National Heart Lung Blood Institute
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Archiving options